Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome
|発行||CBR Pharma Insights||商品コード||278108|
|免疫学の研究戦略：大きな潜在性を持った発展する市場、しかし克服すべき困難な障害を伴う Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome|
|出版日: 2013年07月30日||ページ情報: 英文||
Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.
The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing.
Market access presents a significant hurdle for immunotherapeutics, as many are high cost and do not deliver the measurements required for traditional costeffectiveness assessments.
Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this market but also due to the critical role the immune system plays in the proliferation of cancer throughout the body. Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated.
The report, "Immunology Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome" was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike.